NCT03346187View on ClinicalTrials.gov

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 19, 2017

Primary Completion Date

May 31, 2017

Study Completion Date

June 13, 2017

Conditions
Dyslipidemias
Interventions
DRUG

Active Comparator(Atorvastatin Calcium Trihydrate+Fenofibrate)

Lipitor(Atorvastatin Calcium Trihydrate 20mg/tablet) + Lipidil supra(Fenofibrate 160mg/tablet)

DRUG

Test drug(CKD-337)

CKD-337(Atorvastatin calcium trihydrate 20mg+choline fenofibrate 178.8mg/capsule)

Trial Locations (1)

602-812

Dong-A University Hospital, Busan

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03346187 - A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 | Biotech Hunter | Biotech Hunter